US 12,357,670 B2
Topical cream-based cosmetic and wound healing formulations and methods of use
William P Duncan, Olathe, KS (US); Lauren S Gollahon, Lubbock, TX (US); and William C Putnam, Frisco, TX (US)
Assigned to EIR Pharmaceuticals, LLC, Olathe, KS (US)
Filed by Eir Pharmaceuticals, LLC, Olathe, KS (US)
Filed on Mar. 1, 2023, as Appl. No. 18/115,929.
Application 18/115,929 is a continuation of application No. 16/686,535, filed on Nov. 18, 2019, granted, now 11,607,438.
Application 16/686,535 is a continuation in part of application No. 16/590,807, filed on Oct. 2, 2019, granted, now 11,622,987.
Claims priority of provisional application 62/788,261, filed on Jan. 4, 2019.
Claims priority of provisional application 62/740,047, filed on Oct. 2, 2018.
Prior Publication US 2023/0201296 A1, Jun. 29, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 36/00 (2006.01); A61K 8/19 (2006.01); A61K 8/34 (2006.01); A61K 8/37 (2006.01); A61K 8/64 (2006.01); A61K 8/97 (2017.01); A61K 8/98 (2006.01); A61K 9/06 (2006.01); A61K 31/198 (2006.01); A61K 36/886 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/44 (2017.01); A61P 17/02 (2006.01); A61Q 19/00 (2006.01)
CPC A61K 36/886 (2013.01) [A61K 8/19 (2013.01); A61K 8/342 (2013.01); A61K 8/345 (2013.01); A61K 8/347 (2013.01); A61K 8/375 (2013.01); A61K 8/64 (2013.01); A61K 8/97 (2013.01); A61K 8/987 (2013.01); A61K 9/06 (2013.01); A61K 31/198 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/44 (2013.01); A61P 17/02 (2018.01); A61Q 19/00 (2013.01); A61K 2236/30 (2013.01); A61K 2800/592 (2013.01)] 7 Claims
 
1. A topically-applied hydrogel for the treatment of inflammation, the topically-applied hydrogel comprising:
a gelling agent;
an emollient element;
a humectant;
a preservative; and
an effective amount of an active ingredient mixture consisting of extracts of Cinnamomum cassia, Arctium lappa, Vitex agnus castus, Lonicera japonica, Acanthopanax gracilistylis, Raphanus sativus, Astragalus membranaceus, and Hordeum vulgare.